# FL3 / FL3B delivery review

Decision: GO. Deployment, data preservation and public publication are complete.

Accepted source: `f38e4c4934c377dac69cd563c2ed3ca30b61bf9e`, Financial register19.0.1.2.0. Independent reviewer: icons_release, 2026-09-10.

Independently compared protected before/after snapshots: all 373 original business tables/columns/rows, user memberships and preset assignments are exact. The release evidence records only the expected module version change. Runtime evidence identifies the accepted frozen candidate, HTTP200, expected installed version and no pending module operations.

Both coherent stopped-client backup manifests retain 664 verified attachment references. All 18 referenced backup files were independently checked for size and SHA256. This verifies backup integrity and reference coherence; it does not claim a full restore rehearsal.

MAIN passed 33 row/card checks under PostgreSQL-enforced read-only execution with rollback. The original smoke stopped on its QA-only owner-preset assumption; that failed log is retained. The separately reviewed selector adaptation uses existing active `base.user_admin` ID2 with `su=False` and its three authorized companies; no role/preset was assigned. Its archived runner hash matches main-smoke.json. Frozen application and acceptance artifacts remain unchanged.

No residual runtime/data blocker was found. No financial mutation or test rerun was performed by this reviewer. Incoming/outgoing remains the explicitly approved mixed operational measure, including Applications recognition/settlement adjustments, rather than bank cash or profit.

Publication evidence now records public commit `031264047111ca677f404608543a2d22d0cfc10b` on main, matching the verified remote HEAD with a clean checkout and 1,183 accepted source files. GitHub Actions run `34519359419` completed successfully on that exact public commit. The source binding remains `f38e4c4934c377dac69cd563c2ed3ca30b61bf9e`. The saved github-publication.json was reviewed for this final metadata closure; no tests were repeated. No residual delivery blocker remains.
